CORRELATION BETWEEN C-REACTIVE PROTEIN (CRP) AND BLOOD PRESSURE IN ADULTS
DOI:
https://doi.org/10.61843/jondpac.v4i1.951Keywords:
C-Reactive protein , Blood pressure, Hypertension, Inflammation, AdultsAbstract
C-Reactive Protein (CRP) is a marker of systemic inflammation that increases in chronic inflammatory conditions. Several studies have shown that elevated CRP levels are associated with impaired endothelial function and an increased risk of hypertension. However, the relationship between CRP levels and blood pressure in the adult population still shows varying results. This study aims to determine the correlation between serum CRP levels and blood pressure in adults. This study used a cross-sectional design with a sample size of 30 adult respondents aged 27–60 years who were selected purposively. CRP levels were examined using the Latex Agglutiation method, while blood pressure was measured using a digital sphygmomanometer. Data analysis used Spearman correlation test to determine the relationship between CRP levels and systolic and diastolic blood pressure. The mean CRP levels in respondents were 21 ± 25 mg/L. Statistical analysis showed a significant positive correlation between CRP levels and systolic blood pressure (r = 0.386; p 0.007< 0.05) and diastolic blood pressure (r = -0,048.; p=0,736 > 0.05). Respondents with high CRP levels (>6 mg/L) tended to have higher blood pressure than the group with normal CRP levels. There was a significant positive correlation between CRP levels and systolic blood pressure in adults but no significant correlatrion between CRP levels and diastolic blood pressure in adults. These results indicate that elevated CRP levels can be an early risk indicator for increased blood pressure and potential hypertension. CRP examination can be considered as an additional biomarker in the evaluation of cardiovascular risk.
Downloads
References
Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. (2018). Laporan Nasional Riset Kesehatan Dasar (Riskesdas) 2018 (p. 156). Lembaga Penerbit Balitbangkes. https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/1/Laporan%20Riskesdas%202018%20Nasional.pdf
Novitaningtyas, E. (2014). Hubungan aktivitas fisik dan tekanan darah pada lansia di Kelurahan Makamhaji Kecamatan Kartasura Kabupaten Sukoharjo [Skripsi, Universitas Muhammadiyah Surakarta].
Wuan, A. O., Sari, N. K. Y., Olin, W., & Bia, M. B. (2023, December 19). Screening kadar C-reaktif protein penderita hipertensi pada masyarakat Desa Bone Kecamatan Nekamese Kabupaten Kupang. Swarna: Jurnal Pengabdian Kepada Masyarakat, 2(12), 1223–1229.
Ramadhan Fauzan, D., Irawati, N. A. V., & Fadli, M. Y. (2020). Hipertensi dan inflamasi: Sebuah perspektif ke depan untuk target terapi baru. JK Unila, 4(1).
Harahap, A. U. (2019). Gambaran C-reaktif protein pada penderita hipertensi di RSUD Dr. Pirngadi Medan [Skripsi, Universitas Sumatera Utara].
Dolly, I., & Ariosta. (2018). Hubungan antara high sensitive C-reactive protein (hs-CRP) dan nitric oxide (NO) pada penderita hipertensi. Jurnal Kesehatan, 10(1).
Yeo, W. J., Abraham, R., Surapaneni, A. L., Schlosser, P., Ballew, S., Ozkan, B., et al. (2024). Sex differences in hypertension and its management throughout life. Hypertension, 83(6), 2263–2274.
Pratiwi, F. A. R. (2022). Gambaran hasil pemeriksaan C-reactive protein pada pasien diabetes melitus dan hipertensi di RSUD Dr. Sayidiman Magetan. Brazilian Dental Journal, 33(1), 1–12.
Fadilah, U., & Priyatno, D. (2021). Studi literatur gambaran C-reactive protein pada penderita hipertensi. Jurnal Laboratorium Medis, 2(1), 82–88.
Meliyani, R., & Nurhayati. (2025). Hubungan kepatuhan minum obat terhadap tekanan darah pasien hipertensi di RS Islam Arafah Jambi. Jurnal Kesehatan Arafah, 10–15
Ebong, I. A., Schreiner, P., Lewis, C. E., Appiah, D., Ghelani, A., & Wellons, M. (2016). The association between high-sensitivity C-reactive protein and hypertension in women of the CARDIA study. Menopause (New York, N.Y.), 23(6), 662–668. https://doi.org/10.1097/GME.0000000000000609.
Gupta, N, de Lemos, J, Ayers, C. et al. The Relationship Between C-Reactive Protein and Atherosclerosis Differs on the Basis of Body Mass Index: The Dallas Heart Study. JACC. 2012 Sep, 60 (13) 1148–1155.
https://doi.org/10.1016/j.jacc.2012.04.050.
Richardson, M. R., Johnson, T. M., Katzmarzyk, P. T., Ford, E. S., Boyer, W. R., & Churilla, J. R. (2015). Gender Differences in C-Reactive Protein and Muscle Strengthening Activity. Journal of physical activity & health, 12(12), 1582–1588. https://doi.org/10.1123/jpah.2014-0491
Chen, X., Liu, S., Chu, J., Hu, W., Sun, N., & Shen, Y. (2022). Joint effect of elevated-c-reactive protein level and hypertension on new-onset stroke: A nationwide prospective cohort study of CHARLS. Frontiers in public health, 10, 919506. https://doi.org/10.3389/fpubh.2022.919506
Umboh, A., Wilar, R., Umboh, V., & Krisetya, A. S. (2019). Association between High-Sensitivity C-Reactive Protein and Blood Pressure among Children with History of Low Birth Weight Appropriate for Gestational Age, Low Birth Weight Small for Gestational Age, and Normal Birth Weight in Manado, North Sulawesi. International journal of nephrology, 2019, 3263264. https://doi.org/10.1155/2019/32632
Sesso, H. D., Buring, J. E., Rifai, N., Blake, G. J., Gaziano, J. M., & Ridker, P. M. (2003). C-reactive protein and the risk of developing hypertension. JAMA, 290(22), 2945–2951. https://doi.org/10.1001/jama.290.22.2945
Gallo, G., Volpe, M., & Savoia, C. (2022). Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications. Frontiers in medicine, 8, 798958. https://doi.org/10.3389/fmed.2021.798958
Fatima, Z., Shakeel, R., Chaudhry, S. A. A., Qadri, M., Kakar, A. I., Ahmad, B., Ahmad, T., & Akilimali, A. (2025). The relation between C-reactive protein (CRP) and risk of incident heart failure in patients with cardiovascular disease: a narrative review. Annals of medicine and surgery (2012), 87(7), 4356–4361. https://doi.org/10.1097/MS9.0000000000003455
Kirkgöz K. (2023). C-Reactive Protein in Atherosclerosis-More than a Biomarker, but not Just a Culprit. Reviews in cardiovascular medicine, 24(10), 297. https://doi.org/10.31083/j.rcm2410297
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Hanny Siti Nuraeni, Nilam Andini, Chakrawati, Nadia Guntari, Syed Asim Ali Jafary
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Noncommunicable Diseases Prevention and Control applies the Creative Commons Attribution 4.0 International (CC BY) License, or other comparable licenses that allow free and unrestricted use to articles we publish. If you submit your manuscript for publication by the Journal of Noncommunicable Diseases Prevention and Control, you agree to have the CC BY license applied to your work. If your institution or funder requires your work or materials to be published under a different license or dedicated to the public domain - for example, Creative Commons 1.0 Universal (CC0) or Open Governmental License - this is permitted for those licenses where the terms are equivalent to or more permissive than CC BY.
